Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regadenoson effect on retinal arterioles during hypoxia
NCT03090087Phase 2Unknown
- Sponsor
- Aarhus University
- Start
- Mar 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regadenoson in retinal artery occlusion (RAO), diabetic retinopathy (DR), retinal vein occlusion (RVO), sponsored by Aarhus University. Status: unknown.
02
Drugs
regadenoson
03
Conditions
retinal artery occlusion (RAO)diabetic retinopathy (DR)retinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT03090087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090087.